Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

Bridging the Efficacy-Effectiveness (E-E) gap for cancer therapies

Should effectiveness data be taken into consideration for drug appraisal by regulatory authorities?

Date

21 Oct 2023

Session

Bridging the Efficacy-Effectiveness (E-E) gap for cancer therapies

Topics

Cancer Care Equity Principles and Health Economics

Tumour Site

Presenters

John Cairns

Authors

J. Cairns

Author affiliations

  • London School of Hygiene & Tropical Medicine, London/GB

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Which factors can cause an E-E gap?

Presenter: Hendrik van Halteren

Session: Bridging the Efficacy-Effectiveness (E-E) gap for cancer therapies

Resources:

Slides

Webcast

Discussion

Presenter: All Speakers

Session: Bridging the Efficacy-Effectiveness (E-E) gap for cancer therapies

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.